NSE · KRSNAA · Healthcare
Krsnaa Diagnostics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹173 Cr with net profit ₹43 Cr — a 25.07% net margin, versus 10.34% the period before.
Shareholding
As of 2026-06-30
- Promoter27.11%
- Public54.09%
- FII4.28%
- DII14.51%
53,625 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.74× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #25 of 79 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,29,234 Cr | 244.11 | 13.63 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,09,470 Cr | 73.81 | 10.19 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,634 Cr | 269.56 | 7.24 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,513 Cr | 50.7 | 9.37 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,038 Cr | 298.29 | 9.19 | 8.48% | 8.36% |
| Global Health Limited | ₹38,082 Cr | 264.25 | 9.61 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,895 Cr | 136.55 | 9.04 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,496 Cr | 239.03 | 12.55 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,888 Cr | 51.6 | 5.44 | 10.37% | 17.18% |
| Rainbow Childrens Medicare Ltd. | ₹15,420 Cr | 62.33 | 9.24 | 16.89% | 16.34% |
| Krsnaa Diagnostics Ltd.(this company) | ₹1,700 Cr | 16.76 | 1.73 | 10.35% | 13.13% |
AI analysis
AI-generated · google/gemini-2.5-flashKrsnaa Diagnostics Ltd. is listed on the Indian markets with a market capitalization of Rs 1774 Cr. The company reported a revenue of Rs 742.7 Cr and an EPS of Rs 25.65. The book value per share is Rs 274.65.
Positives
- +The debt-to-equity ratio is 0.21, indicating a low level of debt.
- +No promoter shares are reported as pledged, with promoter pledge at 0%.
Negatives
- −Promoter shareholding has decreased from 66.19% in May 2021 to 27.11% in June 2026.
- −The number of shareholders has decreased from 87,313 in August 2021 to 53,625 in June 2026.
Financial performance
In the fiscal year ending March 2025, Krsnaa Diagnostics Ltd. reported a revenue of Rs 742.695 Cr and a net profit of Rs 77.608 Cr. Quarterly results show a revenue of Rs 192.6 Cr and a net profit of Rs 41.72 Cr for the quarter ending March 2026.
Profitability & returns
The company's Return on Equity (ROE) is 9.7%, and its Return on Capital Employed (ROCE) is 10.42%. The Price-to-Earnings ratio stands at 30.62. The Earnings Per Share (EPS) for the latest reported period is Rs 25.65.
Balance sheet
Krsnaa Diagnostics Ltd. has a debt-to-equity ratio of 0.21. The book value per share is Rs 274.65. The company has a 52-week high of Rs 894.4 and a 52-week low of Rs 515.
Ownership & pledges
As of June 30, 2026, the promoter holding in Krsnaa Diagnostics Ltd. is 27.1146%. Public shareholding is 54.0877%. There are no reported promoter share pledges.
Shareholding changes
Promoter holding has decreased from 66.1872% in May 2021 to 27.1146% in June 2026. Public shareholding has increased from 33.8128% in May 2021 to 54.0877% in June 2026. The number of shareholders has decreased from 87,313 in August 2021 to 53,625 in June 2026.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.